Skip to main content
. Author manuscript; available in PMC: 2022 Apr 28.
Published in final edited form as: Brain Res. 1996 Sep 9;733(1):83–100. doi: 10.1016/0006-8993(96)00541-0

Fig. 5.

Fig. 5.

Behavioral tests on the extracellular levels of dopamine in the ventral tegmental area (VTA) of narcoleptic (n = 4) and control canine group (3 controls, 1 heterozygous) (n = 4) measured by in vivo microdialysis. FECT treatment represents data from six bilateral microdialysis sessions in four narcoleptic canines (two animals tested 2 times, two animals tested 1 time = 11 total observations (one observation run lost due to sample contamination)). MOTOR treatment represents data from four bilateral microdialysis sessions in four narcoleptic canines (each animal tested 1 time = 6 total observations (2 observation runs lost due to sample contamination)). CONTROL treatment represents data from six bilateral microdialysis sessions in four control canines (two animals tested 2 times, two animals tested 1 time = 11 total observations (one observation run lost due to sample contamination)). During FECT treatment each animal performed two FECT trials per 10 min, during MOTOR treatment each animal performed two MOTOR activity trails without having cataplexy per 10 min and during CONTROL treatment each animal performed two FECT trials per 10 min (no cataplexy occurred). Within each group the treatment and post-treatment time points were compared with pretreatment time points (Fishers PLSD post-hoc test). No significant differences were found.